Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
Buffalo Local Index
Buffalo Local Index
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Arena Pharmaceuticals
(NQ:
ARNA
)
N/A
UNCHANGED
Last Price
Updated: 4:00 PM EST, Mar 10, 2022
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Arena Pharmaceuticals
< Previous
1
2
3
Next >
NeurAxis: Should You Buy This IPO?
February 08, 2023
As NeurAxis is ready to launch its IPO, we take a closer look to see if investors should be buying into the hype.
Via
Talk Markets
NeurAxis IPO Sets Stage To Take On Irritable Bowel Syndrome With A Non-Surgical Solution
February 06, 2023
As NeurAxis gears up for its upcoming IPO, we take a deep dive into the company to see if it's worth adding to your investment portfolio.
Via
Talk Markets
Arena Pharmaceuticals Inc. Climbs To Annual-High Share Price
March 10, 2022
This post contains sponsored advertising content. This content is for informational purposes only and not intended to be investing advice. Arena Pharmaceuticals Inc. (NASDAQ: ARNA...
Via
Benzinga
7 Biotech Stocks With Key Catalysts in March
March 09, 2022
These seven stocks have some key catalysts lined up for March with the potential to move their price actions in big ways.
Via
InvestorPlace
Bullish Tuesday For Marijuana Stocks - Nine Energy Service, ReneSola Among Top Gainers
March 08, 2022
GAINERS: Nine Energy Service (NYSE:
Via
Benzinga
Expert Ratings For Arena Pharmaceuticals
February 09, 2022
Arena Pharmaceuticals (NASDAQ:ARNA) has observed the following analyst ratings within the last quarter:
Via
Benzinga
Futures Rebound On "Massive" EU Bond Stimulus Plan; Nickel Halted After Record Surge, Gold Over $2000
March 08, 2022
Futures rebounded from yesterday huge loss, and after touching a session low of 4,138, S&P futures bounced shortly after the European when Bloomberg reported that the European Union was set to reveal a...
Via
Talk Markets
Pfizer's Cannabinoid-Related Biotech Company Arena's Q4 Net Loss Grows 27% YoY
February 24, 2022
Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) revealed Wednesd...
Via
Benzinga
Arena Pharmaceuticals: Q4 Earnings Insights
February 23, 2022
Arena Pharmaceuticals (NASDAQ:ARNA) reported its Q4 earnings results on Wednesday, February 23, 2022 at 04:00 PM. Here's what investors need to know about the announcement....
Via
Benzinga
The Daily Biotech Pulse: Kodiak Sinks On Adverse Study Outcome, Marinus Flags Delay In Clinical Trial, Mainz Biomed Gains On Positive Regulatory Development
February 23, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours. Stocks In Focus Kodiak's Wet AMD Treatment KSI-301 Did Not Meet Primary Endpoint In Phase...
Via
Benzinga
The Week Ahead In Biotech (Feb. 20-26): Reata Awaits FDA Decision, Bausch Health, Moderna Lead Earnings News Flow
February 20, 2022
Biotech stock extended lower for a second straight week as risk aversion continued to pressure stocks amid geopolitical tensions and macroeconomic worries. On the regulatory front...
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For February 9, 2022
February 09, 2022
Upgrades According to Capital One, the prior rating for Federal Realty Investment Trust (NYSE:FRT) was changed from Equal-Weight to Overweight. Federal Realty Investment...
Via
Benzinga
7 Long-Term Stocks to Buy and Hold Until 2030
January 17, 2022
Long-term stocks that promise to be value creators with a robust business model and positive industry tailwinds. Companies that are positioned for robust free cash flows.
Via
InvestorPlace
10 Biggest Price Target Changes For Tuesday
December 21, 2021
B of A Securities lifted the price target on Micron Technology, Inc. (NASDAQ:
Via
Benzinga
Benzinga's Bulls And Bears Of The Past Week: Pfizer, Bank Of America, Beyond Meat, GameStop, AMC, Overstock And More
December 18, 2021
Benzinga has examined the prospects for many investor favorite stocks over the...
Via
Benzinga
The Week In Cannabis: Pfizer, Visa, $730M+ In Financings, Malta, EU, Columbia Care, MedMen, Uruguay And More
December 17, 2021
Below is a recap of the main news related to the cannabis industry and markets for the week of December 13, 2021.
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For December 14, 2021
December 14, 2021
Upgrades According to Wells Fargo, the prior rating for Douglas Emmett Inc (NYSE:
Via
Benzinga
What 6 Analyst Ratings Have To Say About Arena Pharmaceuticals
December 14, 2021
Over the past 3 months, 6 analysts have published their opinion on Arena Pharmaceuticals (NASDAQ:
Via
Benzinga
10 Biggest Price Target Changes For Tuesday
December 14, 2021
B of A Securities lifted the price target on Apple Inc. (NASDAQ: AAPL) from $160 to $210. Apple shares rose 0.4% to $176.37 in pre-market trading. JP Morgan lowered Zscaler,...
Via
Benzinga
58 Biggest Movers From Yesterday
December 14, 2021
Gainers Arena Pharmaceuticals, Inc. (NASDAQ: ARNA) shares jumped 80.4% to close at $90.08 on Monday. Pfizer agreed to acquire Arena Pharmaceuticals for $100 per share in an all-...
Via
Benzinga
Vaccine Stocks Get A Booster As U.K. Plans Third Jab For All
December 13, 2021
Covid vaccine stocks jumped Monday on worries that the omicron variant of the virus could soon overwhelm the United Kingdom.
Via
Investor's Business Daily
Mid-Afternoon Market Update: Dow Tumbles Over 200 Points; BELLUS Health Shares Spike Higher
December 13, 2021
Toward the end of trading Monday, the Dow traded down 0.67% to 35,728.62 while the NASDAQ fell 0.92% to 15,487.41. The S&P also fell, dropping 0.58% to 4,684.47. The U.S. has...
Via
Benzinga
Mid-Day Market Update: Nasdaq Drops Over 100 Points; Foghorn Therapeutics Shares Surge
December 13, 2021
Midway through trading Monday, the Dow traded down 0.81% to 35,679.10 while the NASDAQ fell 0.78% to 15,509.01. The S&P also fell, dropping 0.67% to 4,680.56. The U.S. has the...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
40 Stocks Moving In Monday's Mid-Day Session
December 13, 2021
Gainers Arena Pharmaceuticals, Inc. (NASDAQ: ARNA) shares climbed 83.4% to $91.52. Pfizer agreed to acquire Arena Pharmaceuticals for $100 per share in an all-cash transaction....
Via
Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
December 13, 2021
Gainers Arena Pharmaceuticals (NASDAQ:ARNA...
Via
Benzinga
AMC, GME: What Investors Are Saying as the Top 2 Meme Stocks Tumble Today
December 13, 2021
AMC Entertainment (AMC) and GameStop (GME) are taking a beating today and traders of the meme stocks are reacting on social media.
Via
InvestorPlace
GPRO Stock Price Prediction: Why One Analyst Is Raising Its GoPro Target
December 13, 2021
GoPro (GPRO) stock is rising higher on Monday thanks to a new upgrade and price prediction from Wedbush analyst Alicia Reese.
Via
InvestorPlace
How Pfizer Is Getting Into Cannabis With $6.7B Arena Pharma Deal
December 13, 2021
The two publicly-traded companies confirmed Monday that they have signed a definitive agreement under which Pfizer will acquire all outstanding shares of Arena for $100 per share in an all-cash...
Via
Talk Markets
Topics
Cannabis
Exposures
Cannabis
ARNA Stock Alert: The Pfizer Deal That Has Arena Pharmaceuticals Rocketing Today
December 13, 2021
Arena Pharmaceuticals (ARNA) stock is flying higher on Monday thanks to a huge $6.7 billion acquisition deal with Pfizer (PFE).
Via
InvestorPlace
How Pfizer Is Getting Into Cannabis With $6.7B Arena Pharma Deal
December 13, 2021
Pharmaceutical giant Pfizer Inc. (NYSE:PFE) is e...
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
< Previous
1
2
3
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.